Literature DB >> 12400610

The role of Aktand RAFTK in beta1 integrin mediated survival of precursor B-acute lymphoblastic leukemia cells.

Sibaji Sarkar1, Marek Svoboda, Rosalie de Beaumont, Arnold S Freedman.   

Abstract

In this study, we report that the related adhesion focal tyrosine kinase RAFTK, is an upstream kinase in beta1 integrin mediated activation of Akt. Stimulation through beta1 integrins by fibronectin reversed apoptosis induced by adriamycin. Inhibitors of phosphatidylinositol 3-kinase (PI3 kinase)/Akt (LY 294002), tyrosine kinases (Herbimycin-A) and the cytotoxic agent adriamycin induced apoptosis of REH cells. beta1 integrin ligation induced activation of Akt, and tyrosine phosphorylation of RAFTK and FAK, but not SYK in REH cells. This suggested that RAFTK and FAK activation might be linked to Akt activation. Evidence that RAFTK is a modulator of Akt came from phorbol myristic acetate (PMA) stimulation. RAFTK and Akt were activated but FAK was not. Using fibroblasts from FAK -/- mice, which express high levels of RAFTK, fibronectin plating enhanced Akt activation. Pretreatment of REH cells with a P13 kinase/Akt inhibitor LY 294002 did not inhibit RAFTK tyrosine phosphorylation showing that RAFTK is upstream of P13k/Akt. Further evidence for a link between RAFTK tyrosine phosphorylation and Akt activation was the observation that the p85 subunit of P13 kinase associated with RAFTK following integrin ligation in REH cells. These results suggest that RAFTK plays an anti-apoptotic role through the activation of Akt.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12400610     DOI: 10.1080/1042819021000003009

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  Subcutaneous passage increases cell aggressiveness in a xenograft model of diffuse large B cell lymphoma.

Authors:  Rosa Bosch; María José Moreno; Rebeca Dieguez-Gonzalez; María Virtudes Céspedes; Alberto Gallardo; Josep Nomdedeu; Miguel Angel Pavón; Iñigo Espinosa; Maria Antònia Mangues; Jorge Sierra; Isolda Casanova; Ramon Mangues
Journal:  Clin Exp Metastasis       Date:  2012-01-20       Impact factor: 5.150

2.  T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.

Authors:  Sibaji Sarkar; Douglas V Faller
Journal:  Oligonucleotides       Date:  2011-01-31

3.  B cell receptor-induced phosphorylation of Pyk2 and focal adhesion kinase involves integrins and the Rap GTPases and is required for B cell spreading.

Authors:  Kathy W K Tse; May Dang-Lawson; Rosaline L Lee; Doris Vong; Anica Bulic; Leonard Buckbinder; Michael R Gold
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

Review 4.  Cancer development, progression, and therapy: an epigenetic overview.

Authors:  Sibaji Sarkar; Garrick Horn; Kimberly Moulton; Anuja Oza; Shannon Byler; Shannon Kokolus; McKenna Longacre
Journal:  Int J Mol Sci       Date:  2013-10-21       Impact factor: 5.923

Review 5.  Integrin-Mediated Adhesion and Chemoresistance of Acute Lymphoblastic Leukemia Cells Residing in the Bone Marrow or the Central Nervous System.

Authors:  Bibi Fatima Syed Shah Scharff; Signe Modvig; Hanne Vibeke Marquart; Claus Christensen
Journal:  Front Oncol       Date:  2020-05-22       Impact factor: 6.244

Review 6.  The bone marrow microenvironment as a mediator of chemoresistance in acute lymphoblastic leukemia.

Authors:  Lauren K Meyer; Michelle L Hermiston
Journal:  Cancer Drug Resist       Date:  2019-12-19

7.  The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias.

Authors:  I S Mahmoud; M A Sughayer; H A Mohammad; A S Awidi; M S EL-Khateeb; S I Ismail
Journal:  Br J Cancer       Date:  2008-08-05       Impact factor: 7.640

Review 8.  Drug resistance in cancer: an overview.

Authors:  Genevieve Housman; Shannon Byler; Sarah Heerboth; Karolina Lapinska; Mckenna Longacre; Nicole Snyder; Sibaji Sarkar
Journal:  Cancers (Basel)       Date:  2014-09-05       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.